Correlation Between Briacell Therapeutics and Vanguard Total

Can any of the company-specific risk be diversified away by investing in both Briacell Therapeutics and Vanguard Total at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Briacell Therapeutics and Vanguard Total into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Briacell Therapeutics Corp and Vanguard Total Stock, you can compare the effects of market volatilities on Briacell Therapeutics and Vanguard Total and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Briacell Therapeutics with a short position of Vanguard Total. Check out your portfolio center. Please also check ongoing floating volatility patterns of Briacell Therapeutics and Vanguard Total.

Diversification Opportunities for Briacell Therapeutics and Vanguard Total

-0.8

Correlation Coefficient

Briacell Therapeutics  Vanguard Total

Pay attention - limited upside

The 3 months correlation between Briacell and Vanguard is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Briacell Therapeutics Corp and Vanguard Total Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Total Stock and Briacell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Briacell Therapeutics Corp are associated (or correlated) with Vanguard Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Total Stock has no effect on the direction of Briacell Therapeutics i.e., Briacell Therapeutics and Vanguard Total go up and down completely randomly.

Pair Corralation between Briacell Therapeutics and Vanguard Total

Given the investment horizon of 90 days Briacell Therapeutics Corp is expected to generate 8.89 times more return on investment than Vanguard Total. However, Briacell Therapeutics is 8.89 times more volatile than Vanguard Total Stock. It trades about 0.0 of its potential returns per unit of risk. Vanguard Total Stock is currently generating about -0.29 per unit of risk. If you would invest  224.00  in Briacell Therapeutics Corp on January 20, 2024 and sell it today you would lose (9.00) from holding Briacell Therapeutics Corp or give up 4.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Briacell Therapeutics Corp  vs.  Vanguard Total Stock

Briacell Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Briacell Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Vanguard Total Stock

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Vanguard Total Stock are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Vanguard Total is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Briacell Therapeutics and Vanguard Total

The main advantage of trading using opposite Briacell Therapeutics and Vanguard Total positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Briacell Therapeutics position performs unexpectedly, Vanguard Total can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Total will offset losses from the drop in Vanguard Total's long position.

The idea behind Briacell Therapeutics Corp and Vanguard Total Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.